Medical Device Pricing is hospital group-purchasing and opaque contracting inflate device costs far above marginal cost. It sits in the Incentives dimension (INC) of the Human Behavior Taxonomy™ as element HBT-INC-0175, within the Healthcare Perverse Pattern family. The core principle: hospital group-purchasing and opaque contracting inflate device costs far above marginal cost. In incentive terms, it matters because it changes the payoff people perceive before they choose — which means it can be designed for, or exploited.
Scientific Definition
Hospital group-purchasing and opaque contracting inflate device costs far above marginal cost.
Plain-English Definition
Hospital group-purchasing and opaque contracting inflate device costs far above marginal cost.
Feynman Explanation
The screw costs $2. The compliance theater around it costs $2,000.
Core Principle
Hospital group-purchasing and opaque contracting inflate device costs far above marginal cost.
Mechanisms
Pending editorial review.
Hospital group-purchasing and opaque contracting inflate device costs far above marginal cost.
Pending editorial review.
Pending editorial review.
Procurement opacity is a profit pool, not a bug.
Pending editorial review.
Pending editorial review.
Inputs (Triggers)
Pending editorial review.
Outputs (Behaviors)
Pending editorial review.
Behavioral Signature
The screw costs $2. The compliance theater around it costs $2,000.
Examples
- Identical implants priced 5–10x across hospitals in the same city.
- Procurement opacity is a profit pool, not a bug.
Pending editorial review.
Original analysis from The Incentives Lab — how this element behaves inside real payoff structures.
Why this element matters to incentive design
This element is common enough to feel like human nature and specific enough to be engineered around. The mechanism underneath it is straightforward: hospital group-purchasing and opaque contracting inflate device costs far above marginal cost. You can recognize it in the field by its signature: the screw costs $2. The compliance theater around it costs $2,000. Every element in the Incentives dimension changes the perceived payoff of an action before the action happens, which is exactly where incentive design has leverage.
How it gets exploited
Left undesigned, procurement opacity is a profit pool, not a bug. It is amplified whenever procurement opacity is a profit pool, not a bug. Inside organizations that shows up as procurement opacity is a profit pool, not a bug. The pattern is the same one Goodhart's Law describes: the measurable proxy attracts the effort, and the purpose behind it quietly loses funding.
How the Lab designs around it
The redesign move is to price transparency mandates. Reference pricing. Direct-from-manufacturer rails. Watch for it at the boundaries: handoffs, promotions, incident reviews, and budget cycles are where this element gets its power.
Famous Experiments
Pending editorial review.
Design Principles
- Price transparency mandates. Reference pricing. Direct-from-manufacturer rails.
Measurement Approaches
Pending editorial review.
Evidence
Pending editorial review.
Pending editorial review.
The Perverse Incentive Lens™
How this behavior is exploited — and how to redesign around it.
- Price transparency mandates. Reference pricing. Direct-from-manufacturer rails.
Pending editorial review.
Pending editorial review.
Interactive Mini Network
Click any neighbor to re-center the graph and follow the threads of connection.
Knowledge Graph Neighbors
Auto-linked to the rest of the Human Behavior Taxonomy by family, domain, dimension, and shared keywords.
Productivity targets compress visits, raising misdiagnosis and burnout.
A federal mandate intended to lower drug costs for the poor became a profit engine for hospitals and contract pharmacies.
Liability exposure pushes clinicians to order tests for legal protection rather than clinical need.
Federal reimbursement rules incentivize cycling seniors through hospitalizations to upgrade billing categories.
Paying providers per procedure rewards more procedures, not better outcomes.
Systems paid per filled bed have weak incentives to invest in prevention or community health.
Opaque billing rules create lucrative work for administrators and revenue-cycle firms instead of care.
Insurers profit when claims are denied, delayed, or abandoned.
Sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis.
Federal incentives meant for neglected diseases get used to privatize widely available medicines.
Drug companies optimize for high-margin chronic conditions, not cures.
Specialists earn more for procedures than primary care for prevention.
Where Medical Device Pricing is cited in the corpus
Essays, field guides, and diagnostics from The Incentives Lab that apply this element.
- Field guideIncentives: definition, types, examples
The parent field guide for this element.
- ReferenceThe laws of incentives
Goodhart, Campbell, and the Cobra Effect.
- ReferenceThe incentive glossary
Definitions for every mental model, bias, and fallacy in the corpus.
- ReferenceThe Periodic Table of Human Behavior
The full 1,267-element map this page belongs to.
Questions about Medical Device Pricing
- What is Medical Device Pricing?
- Medical Device Pricing is hospital group-purchasing and opaque contracting inflate device costs far above marginal cost. It sits in the Incentives dimension (INC) of the Human Behavior Taxonomy™ as element HBT-INC-0175, within the Healthcare Perverse Pattern family. The core principle: hospital group-purchasing and opaque contracting inflate device costs far above marginal cost. In incentive terms, it matters because it changes the payoff people perceive before they choose — which means it can be designed for, or exploited.
- What is an example of Medical Device Pricing?
- Procurement opacity is a profit pool, not a bug. The Incentives Lab catalogs everyday, organizational, and historical instances of this element on its Human Behavior Taxonomy™ page (HBT-INC-0175).
- How is Medical Device Pricing exploited?
- Procurement opacity is a profit pool, not a bug.
- How do you design around Medical Device Pricing?
- Price transparency mandates. Reference pricing. Direct-from-manufacturer rails.
- Which behavioral dimension does Medical Device Pricing belong to?
- Medical Device Pricing is classified in the Incentives dimension (INC) of the Human Behavior Taxonomy™, family "Healthcare Perverse Pattern", class "Perverse Incentive". Its permanent identifier is HBT-INC-0175 and its evidence grade is C.